Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical companies, such as the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to complete so may possibly be grounds for compensation. Our lawyers are operating challenging to obtain those hurt by the drug the compensation they're entitled to.While bleeding is actually a typical complication associated with anticoagulants, it has been alleged that Xarelto is far more unsafe than classic blood thinners simply because no antidote exists to reverse its blood-thinning effects. This signifies that, inside the event of an emergency, individuals could be at danger for irreversible bleeding issues, such as life-threatening internal and gastrointestinal hemorrhaging.In the event you or perhaps a loved one suffered a critical bleeding event soon after taking Xarelto, you may have legal recourse. For much more data, make contact with us nowadays to have your case reviewed, free of charge of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future health-related bills, lost wages, pain and suffering and, in situations of death, funeral expenses. Additionally, they're in search of punitive damages, which are usually awarded to punish the defendant and deter other companies from acting similarly.Why Are Lawsuits Becoming Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs inside the lawsuits allege serious and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the official source drug continue to market Xarelto as a protected anticoagulant option.Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.Visit this page for a lot more details on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.